Aibotics Inc.

AIBT ·Healthcare, Drug Manufacturers - General, United States
Valuation › AI Valuation

AI Valuation

AI-generated fair value estimate for this company.

AI Fair Value $0.00
Market Price $0.00
Overvalued By 866.7%

Method: Net asset plus risk-adjusted option value: total liabilities of $5.15M exceed total assets giving negative equity of -$4.60M so pure liquidation value per share floors at $0; added a probability-weighted option value for PHILL robot commercialization (success case ~$5M revenue/$750K net income at 12x earnings = ~$9M equity value, discounted 3 years at 25% and weighted at a 5% success probability given going-concern doubt) yielding about $230K of expected value across roughly 682M shares outstanding.

Reasoning: Aibotics is a pre-revenue early-stage robotics/psychedelics R&D company with a real product in production (PHILL robot, 3DX Industries manufacturing deal, ~650 presales), so per the pre-revenue-tech carve-out it is valued on optionality rather than skipped, but negative shareholder equity, going-concern language, and repeated late filings warrant a heavy probability discount.